Q1 2020 Adaptimmune Therapeutics PLC Earnings Call Transcript
Ladies and gentlemen, thank you for standing by, and welcome to the Adaptimmune Q1 2020 Earnings Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions)
I would now like to hand the conference over to your speaker today, Ms. Juli Miller. Thank you. Please go ahead, ma'am.
Good morning, and welcome to Adaptimmune's conference call to discuss our first quarter 2020 financial results. We issued a press release earlier this morning, and I would ask you to please review the full text of our forward-looking statements there. We anticipate making projections during this call and actual results could differ materially due to a number of factors including those outlined in our latest filings with the SEC.
Adrian Rawcliffe, our CEO, is with me for the prepared portion of this call and other members of our management team will be available for Q&A. With that, I'll turn the call over to Adrian Rawcliffe. Ad?
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |